RYKINDO Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Rykindo, and what generic alternatives are available?
Rykindo is a drug marketed by Shandong Luye and is included in one NDA. There are five patents protecting this drug.
This drug has thirty-three patent family members in fourteen countries.
The generic ingredient in RYKINDO is risperidone. There are thirty drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the risperidone profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Rykindo
A generic version of RYKINDO was approved as risperidone by APOTEX INC on September 15th, 2008.
Summary for RYKINDO
International Patents: | 33 |
US Patents: | 5 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 143 |
Patent Applications: | 1,791 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in RYKINDO? | RYKINDO excipients list |
DailyMed Link: | RYKINDO at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for RYKINDO
US Patents and Regulatory Information for RYKINDO
RYKINDO is protected by five US patents.
Patents protecting RYKINDO
Risperidone sustained release microsphere composition
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TREATMENT OF SCHIZOPHRENIA IN ADULTS
Risperidone sustained release microsphere composition
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TREATMENT OF SCHIZOPHRENIA IN ADULTS
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Risperidone sustained release microsphere composition
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TREATMENT OF SCHIZOPHRENIA IN ADULTS
Risperidone sustained release microsphere composition
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TREATMENT OF SCHIZOPHRENIA IN ADULTS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shandong Luye | RYKINDO | risperidone | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 212849-001 | Jan 13, 2023 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Shandong Luye | RYKINDO | risperidone | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 212849-004 | Jan 13, 2023 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Shandong Luye | RYKINDO | risperidone | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 212849-002 | Jan 13, 2023 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Shandong Luye | RYKINDO | risperidone | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 212849-001 | Jan 13, 2023 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Shandong Luye | RYKINDO | risperidone | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 212849-003 | Jan 13, 2023 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Shandong Luye | RYKINDO | risperidone | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 212849-004 | Jan 13, 2023 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
EU/EMA Drug Approvals for RYKINDO
Company | Drugname | Inn | Product Number / Indication | Status | Generic | Biosimilar | Orphan | Marketing Authorisation | Marketing Refusal |
---|---|---|---|---|---|---|---|---|---|
Laboratorios Farmacéuticos Rovi, S.A. | Okedi | risperidone | EMEA/H/C/005406 Treatment of schizophrenia in adults for whom tolerability and effectiveness has been established with oral risperidone. |
Authorised | no | no | no | 2022-02-14 | |
>Company | >Drugname | >Inn | >Product Number / Indication | >Status | >Generic | >Biosimilar | >Orphan | >Marketing Authorisation | >Marketing Refusal |
International Patents for RYKINDO
See the table below for patents covering RYKINDO around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
South Korea | 20150050598 | 리스페리돈의 서방성 미소구체 조성물 (RISPERIDONE SUSTAINED RELEASE MICROSPHERE COMPOSITION) | ⤷ Try a Trial |
European Patent Office | 2701687 | COMPOSITION DE MICROSPHÈRES DE RISPÉRIDONE À LIBÉRATION PROLONGÉE (RISPERIDONE SUSTAINED RELEASE MICROSPHERE COMPOSITION) | ⤷ Try a Trial |
Brazil | 112013027235 | composição de microesferas de desprendimento sustentado de risperidona | ⤷ Try a Trial |
Hungary | E046004 | ⤷ Try a Trial | |
Portugal | 3199146 | ⤷ Try a Trial | |
South Korea | 20140026481 | 리스페리돈의 서방성 미소구체 조성물 (RISPERIDONE SUSTAINED RELEASE MICROSPHERE COMPOSITION) | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for RYKINDO
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0196132 | 94C0008 | Belgium | ⤷ Try a Trial | PRODUCT NAME: RISPERIDONE; NAT REG.: 2 S 414 F 3 19940527; FIRST REG.: GB 0242/0186 19921208 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |